DeuterOncology

{
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-05-12",
    "filing_date": "2026-03-27",
    "act_kind_objet": "D\u00E9mission et nomination du pr\u00E9sident du conseil d\u0027administration"
  },
  "key_dates": [
    {
      "date": "2026-04-30",
      "label": "date de l\u0027acte"
    },
    {
      "date": "2026-03-27",
      "label": "date de la d\u00E9cision \u00E9crite du conseil d\u0027administration"
    }
  ],
  "key_parties": [
    {
      "kbo": "0862727797",
      "kind": "org",
      "name": "VIZIPHAR Biosciences SRL",
      "role": "pr\u00E9sident du conseil d\u0027administration"
    },
    {
      "kind": "person",
      "name": "Van Reet Gustaaf",
      "role": "pr\u00E9sident du conseil d\u0027administration"
    },
    {
      "kind": "person",
      "name": "Huerga Sanchez Iker",
      "role": "pr\u00E9sident du conseil d\u0027administration"
    },
    {
      "kind": "person",
      "name": "Christoph Michiels",
      "role": "Mandataire sp\u00E9cial"
    },
    {
      "kind": "person",
      "name": "Enkeleta Fazliu",
      "role": "Mandataire sp\u00E9cial"
    },
    {
      "kind": "person",
      "name": "Nicolas Bosschaerts",
      "role": "Mandataire sp\u00E9cial"
    },
    {
      "kind": "person",
      "name": "Anthea Debou",
      "role": "Mandataire sp\u00E9cial"
    },
    {
      "kind": "org",
      "name": "Deloitte Legal - Lawyers",
      "role": ""
    }
  ],
  "key_amounts_eur": [],
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": null
  },
  "summary_narrative": "",
  "co_filed_documents": [],
  "detected_real_type": "board_change"
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "detected_kind": "officer_designation",
  "effective_date": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": null
  },
  "liquidation_closure": null,
  "officer_designation": {
    "role": "pr\u00E9sident du conseil d\u0027administration",
    "quote": "nommer Huerga Sanchez Iker en tant que pr\u00E9sident du conseil d\u0027administration, avec effet imm\u00E9diat et pour une dur\u00E9e ind\u00E9termin\u00E9e.",
    "person_name": "Huerga Sanchez Iker",
    "person_or_entity_kbo": null
  },
  "special_procuration": null,
  "single_shareholder_declaration": null
}

{
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-05-12",
    "filing_date": "2026-03-27",
    "act_kind_objet": "D\u00E9mission et nomination du pr\u00E9sident du conseil d\u0027administration"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2026-03-27",
    "unanimous": true
  },
  "agm_change": null,
  "detected_kind": "officer_designation",
  "other_address": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "SA"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Anthea Debou",
    "org_rep_person_name": null
  },
  "co_filed_documents": [],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": {
    "role": "president",
    "organ": "raad_van_bestuur",
    "person_name": "Huerga Sanchez Iker"
  },
  "special_procuration": {
    "grantee_kbo": null,
    "grantee_name": "Christoph Michiels, Enkeleta Fazliu, Nicolas Bosschaerts et Anthea Debou",
    "grantor_name": "DeuterOncology",
    "scope_summary": "A power of attorney is granted to four lawyers from Deloitte Legal - Lawyers to publish the decisions in the Moniteur belge, complete the formalities for modifying the company\u0027s registration in the Bank-Corpus of Enterprises and with the VAT administration, and to sign any document and act, including publication forms and special forms to be submitted to the company counters.",
    "monetary_cap_eur": null,
    "scope_categories": [
      "publication",
      "tax",
      "personnel"
    ],
    "termination_clause": null,
    "substitution_allowed": false
  },
  "is_volet_a_only_stub": false,
  "vakbekwaamheid_change": null,
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 11668457.45,
      "delta_eur": 3070286.3,
      "before_eur": 8598171.15,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "B",
        "n_new_shares": 296621,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 1067227,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Preferent",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 95976,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 10,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 5,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 30,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 13350145.0,
      "delta_eur": 1681687.55,
      "before_eur": 11668457.45,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 396063,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 16683478.0,
      "delta_eur": 3333333.0,
      "before_eur": 13350145.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 785052,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 3333333.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-04-08",
    "filing_date": "2026-04-03",
    "act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS, DEMISSIONS, NOMINATIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2026-03-27",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "BDO BEDRIJFSREVISOREN-BDO REVISEURS D\u2019ENTREPRISES",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Veerle Catry"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "BERQUIN NOTAIRES",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "procurations",
    "texte coordonn\u00E9 des statuts",
    "rapport de l\u0027organe d\u0027administration",
    "rapport du commissaire"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 1119227,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 1181115,
      "class_name": "Preferent",
      "capital_share_eur": null,
      "voting_rights_per_share": 3.0
    }
  ]
}

{
  "events": [
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO BEDRIJFSREVISOREN-BDO REVISEURS D\u2019ENTREPRISES",
        "address": "Da Vincilaan 9 \u2013 bo\u00EEte E.6",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 7:197 et l\u2019article 7:179 du CSA, nous pr\u00E9sentons notre conclusion \u00E0 l\u2019 assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 DeuterOncology SA (ci-apr\u00E8s \u00AB la Soci\u00E9t\u00E9 \u00BB) dans le cadre de notre mission de commissaire pour laquelle nous avons \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 20 ",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Newton Biocapital Partners BV/SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners BV/SRL",
        "address": null,
        "country": null,
        "legal_form": "BV/SRL"
      },
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2032"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "NOSHAQ PARTNERS BV/SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS BV/SRL",
        "address": null,
        "country": null,
        "legal_form": "BV/SRL"
      },
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2032"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "HUERGA Iker",
        "address": null,
        "birth_date": "1982-03-30",
        "profession": null,
        "birth_place": "Spain"
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2032"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "DAVIS Kipp Richard Fairchild",
        "address": null,
        "birth_date": "1980-12-15",
        "profession": null,
        "birth_place": "New York, United States"
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2032"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "DOLAN Alexander Patrick",
        "address": null,
        "birth_date": "1987-04-08",
        "profession": null,
        "birth_place": "Florida, United States"
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2032"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "rep_rotation",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Pierre Detrixhe",
        "address": null,
        "birth_date": "1976-04-22",
        "profession": null,
        "birth_place": "Hermalle-sous-Argenteau"
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-01-01",
      "evidence_quote": "Pierre Detrixhe a \u00E9t\u00E9 d\u00E9sign\u00E9 en tant que nouveau repr\u00E9sentant permanent de l\u0027entreprise Newton Biocapital Partners SRL/BV, administrateur-personne morale, rempla\u00E7ant Jean Combalbert avec effet au 1 janvier 2025.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": "Jean Combalbert",
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO R\u00E9viseurs d\u2019Entreprises SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 7:197 et l\u2019article 7:179 du CSA, nous pr\u00E9sentons notre conclusion \u00E0 l\u2019 assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 DeuterOncology SA (ci-apr\u00E8s \u00AB la Soci\u00E9t\u00E9 \u00BB) dans le cadre de notre mission de commissaire pour laquelle nous avons \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 20 ",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-04-08",
    "filing_date": "2026-04-03",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2026-03-27",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2021-02-04",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2023-06-20",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-06-20",
      "unanimous": null
    },
    {
      "body": "algemene_vergadering",
      "date": "2026-03-27",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "BERQUIN NOTAIRES",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "huit procurations",
    "le texte coordonn\u00E9 des statuts",
    "le rapport de l\u0027organe d\u0027administration",
    "le rapport du commissaire \u00E9tabli en application de l\u0027article 7:155 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport de l\u0027organe d\u0027administration et le rapport du commissaire \u00E9tabli en application des articles 7:179, \u00A71, deuxi\u00E8me alin\u00E9a et 7:197, \u00A71, deuxi\u00E8me alin\u00E9a du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "corrected_publication_numac": null
}

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-04-08",
    "filing_date": "2026-04-03",
    "act_kind_objet": "CAPITAL, ACTIONS, DEMISSIONS, NOMINATIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2026-03-27",
    "unanimous": true
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "legal_form_change",
      "wvv_adaptation",
      "name_change",
      "object_change",
      "duration_change",
      "share_split",
      "share_consolidation",
      "share_class_creation",
      "board_authorized_capital",
      "governance_restructure",
      "liquidation_preference_introduction",
      "seat_region_change"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "bilingual",
    "language_before": "bilingual"
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "BDO BEDRIJFSREVISOREN-BDO REVISEURS D\u2019ENTREPRISES",
    "ibr_number": null,
    "individual_name": "Veerle Catry"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full_after": "DeuterOncology",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "DeuterOncology",
    "current_zetel_raw": "Clos Chanmurly 13 4000 Li\u00E8ge",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Berquin Notarissen BV/SRL",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Christoph Michiels",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Enkeleta Fazliu",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Brent Mastin",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "The company\u0027s legal form is confirmed as a soci\u00E9t\u00E9 anonyme, and its name is set to \u0022DeuterOncology\u0022.",
      "new_text": "La soci\u00E9t\u00E9 rev\u00EAt la forme d\u0027une soci\u00E9t\u00E9 anonyme. \nElle est d\u00E9nomm\u00E9e \u0022DeuterOncology\u0022.",
      "change_kind": "restated",
      "article_title": "FORME JURIDIQUE - DENOMINATION",
      "article_number": "1"
    },
    {
      "summary": "The company\u0027s registered office is established in the Wallonia region, with the possibility to establish administrative, operational, and branch offices in Belgium or abroad.",
      "new_text": "Le si\u00E8ge de la soci\u00E9t\u00E9 est \u00E9tabli en R\u00E9gion wallonne.\nLa soci\u00E9t\u00E9 peut \u00E9tablir, par d\u00E9cision de l\u2019organe d\u0027administration, des si\u00E8ges administratifs, des\nsi\u00E8ges d\u0027exploitation, des succursales et des d\u00E9p\u00F4ts en Belgique ou \u00E0 l\u0027\u00E9tranger.",
      "change_kind": "restated",
      "article_title": "SIEGE",
      "article_number": "2"
    },
    {
      "summary": "The company\u0027s object is comprehensively restated to include research, development, and commercialization of pharmaceutical, veterinary, and biological products, as well as related supplies and personalized medicine.",
      "new_text": "La soci\u00E9t\u00E9 a pour objet :\nA/ La recherche scientifique, l\u0027\u00E9tude clinique, les essais, l\u0027analyse et l\u0027\u00E9valuation, le\nd\u00E9veloppement clinique, l\u0027achat, la fabrication, l\u0027octroi de licences ou la prise de licences, la vente,\nl\u0027importation et l\u0027exportation, la location et, en g\u00E9n\u00E9ral, la conclusion de toutes les transactions\npossibles concernant les produits pharmaceutiques, v\u00E9t\u00E9rinaires, biologiques, ",
      "change_kind": "restated",
      "article_title": "OBJET",
      "article_number": "3"
    },
    {
      "summary": "The company exists for an unlimited duration.",
      "new_text": "La soci\u00E9t\u00E9 existe pour une dur\u00E9e illimit\u00E9e.",
      "change_kind": "restated",
      "article_title": "DUREE",
      "article_number": "4"
    },
    {
      "summary": "The capital is fixed at \u20AC16,683,478.00, represented by 2,300,342 shares without nominal value, consisting of 1,119,227 Ordinary and 1,181,115 Preferential shares.",
      "new_text": "5.1. Capital \u00E9mis\nLe capital est fix\u00E9 \u00E0 seize millions six cent quatre-vingt-trois mille quatre cent septante-huit euros (\u20AC\n16.683.478,00).\nIl est repr\u00E9sent\u00E9 par deux million trois cent mille trois cent quarante-deux (2.300.342) actions, sans\nmention de valeur nominale, dont :\n- un million cent dix-neuf mille deux-cent vingt-sept (1.119.227) Actions Ordinaires ;\n- un million cent quatre-vingt-et-u",
      "change_kind": "restated",
      "article_title": "CAPITAL",
      "article_number": "5"
    },
    {
      "summary": "The company is administered by a board of up to five members, elected by the general meeting, with specific nomination rights for preferential and ordinary shareholders.",
      "new_text": "La soci\u00E9t\u00E9 est administr\u00E9e par un conseil d\u2019administration, qui est compos\u00E9 de cinq (5) membres au\nmaximum, nomm\u00E9s par l\u0027assembl\u00E9e g\u00E9n\u00E9rale, et qui est compos\u00E9 comme suit :\n- la majorit\u00E9 des membres (p.e. 3 des 5 membres, 3 des 4 membres ou 2 des 3 membres)\nsont \u00E9lus sur proposition de l\u2019Actionnaire Pr\u00E9f\u00E9rentiel (les Administrateurs Pr\u00E9f\u00E9rentiels) ; et\n- les membres restants sont \u00E9lus sur proposit",
      "change_kind": "restated",
      "article_title": "COMPOSITION DE L\u2019ORGANE D\u0027ADMINISTRA\u00ACTION",
      "article_number": "8"
    },
    {
      "summary": "The board of directors is invested with the widest powers to perform all acts necessary or useful for the realization of the company\u0027s object, with the exception of those reserved by law for the general meeting.",
      "new_text": "Le conseil d\u0027administration est investi des pouvoirs les plus \u00E9tendus pour accomplir tous les actes\nn\u00E9cessaires ou utiles \u00E0 la r\u00E9alisation de l\u0027objet de la soci\u00E9t\u00E9, \u00E0 l\u0027exception de ceux que la loi r\u00E9serve \u00E0",
      "change_kind": "restated",
      "article_title": "POUVOIR DE GESTION \u2013 GESTION JOURNALERE",
      "article_number": "10"
    },
    {
      "summary": "The board of directors represents the company towards third parties and in court. The company is also validly represented by two administrators acting jointly, at least one of whom is a Preferential Administrator, with power of substitution.",
      "new_text": "Le conseil d\u2019administration repr\u00E9sente la soci\u00E9t\u00E9 \u00E0 l\u2019\u00E9gard des tiers et en justice, en tant que\ndemandeur ou d\u00E9fendeur.\nLa soci\u00E9t\u00E9 est \u00E9galement valablement repr\u00E9sent\u00E9e \u00E0 l\u2019\u00E9gard des tiers et en justice, en tant que",
      "change_kind": "restated",
      "article_title": "POUVOIR DE REPRESENTATION",
      "article_number": "11"
    },
    {
      "summary": "The ordinary general meeting meets on the last Friday of May at 10:00. If this day is a Saturday, Sunday, or holiday, the meeting takes place on the first following working day.",
      "new_text": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire se r\u00E9unit le dernier vendredi du mois de mai \u00E0 10 heures. \nSi ce jour est un samedi, un dimanche ou un jour f\u00E9ri\u00E9, l\u0027assembl\u00E9e g\u00E9n\u00E9rale a lieu le premier jour",
      "change_kind": "restated",
      "article_title": "DATE ASSEMBLEE GENERALE ORDINAIRE - ASSEMBLEE GENERALE SPECIALE /\nEXTRAORDINAIRE",
      "article_number": "13"
    },
    {
      "summary": "To be admitted to the general meeting, holders of titles must deposit their (certificates of) titles at the seat or at the designated establishments at least three working days before the date fixed for the meeting, if the convocation requires it.",
      "new_text": "Pour \u00EAtre admis \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale, les d\u00E9tenteurs de titres, qui ont le droit d\u2019\u00EAtre convoqu\u00E9s\nconform\u00E9ment aux dispositions l\u00E9gales applicables, doivent, si la convocation l\u0027exige, au moins trois",
      "change_kind": "restated",
      "article_title": "ADMISSION \u00C0 L\u2019ASSEMBLEE GENERALE",
      "article_number": "16"
    },
    {
      "summary": "Any shareholder may be represented at the general meeting by a proxy, shareholder or not. The powers of attorney must be communicated in writing, by letter or by e-mail or by any other means of communication that materializes in a written document at the recipient.",
      "new_text": "Tout actionnaire peut se faire repr\u00E9senter \u00E0 l\u2019assembl\u00E9e g\u00E9n\u00E9rale par un mandataire, actionnaire ou\nnon. Les procurations doivent comporter une signature.\nLes procurations doivent \u00EAtre communiqu\u00E9es par \u00E9crit, par lettre ou par e-mail ou par tout autre",
      "change_kind": "restated",
      "article_title": "REPRESENTATION",
      "article_number": "17"
    },
    {
      "summary": "Each Ordinary share gives the right to one vote, and each Preferential share gives the right to three votes. Shareholders may participate in the general meeting at a distance via an electronic communication means provided by the company.",
      "new_text": "Chaque Action Ordinaire donne droit \u00E0 une voix, et chaque Action Pr\u00E9f\u00E9rentielle donne droit \u00E0 trois\nvoix.\nChaque actionnaire peut participer \u00E0 distance \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale par le biais d\u0027un moyen de",
      "change_kind": "restated",
      "article_title": "DROIT DE VOTE",
      "article_number": "21"
    },
    {
      "summary": "The fiscal year begins on January 1st and ends on December 31st of each year.",
      "new_text": "L\u0027exercice social commence le 1er janvier pour se terminer le 31 d\u00E9cembre de chaque ann\u00E9e.",
      "change_kind": "restated",
      "article_title": "EXERCICE SOCIAL \u2013 COMPTES ANNUELS \u2013 RAPPORT ANNUEL",
      "article_number": "23"
    },
    {
      "summary": "If and as long as the law requires, an annual deduction of at least five percent (5%) is made on the net profits of the company for the constitution of the legal reserve.",
      "new_text": "Si et aussi longtemps que la loi l\u2019exige, il est effectu\u00E9 annuellement sur les b\u00E9n\u00E9fices nets de la\nsoci\u00E9t\u00E9 un pr\u00E9l\u00E8vement de cinq pourcent (5%) au moins qui est affect\u00E9 \u00E0 la constitution de la r\u00E9serve",
      "change_kind": "restated",
      "article_title": "REPARTITION DES BENEFICES",
      "article_number": "24"
    },
    {
      "summary": "The company can be dissolved at any time by a decision of the general meeting deliberating in the manner required by law, or is dissolved in the cases provided by law. During dissolution with liquidation, one or more liquidators are appointed if necessary by the general meeting.",
      "new_text": "26.1. Dissolution et liquidation\nLa soci\u00E9t\u00E9 peut en tout temps \u00EAtre dissoute par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui d\u00E9lib\u00E8re de la\nmani\u00E8re requise par la loi, ou est dissoute dans les cas pr\u00E9vus par la loi. \nLors de la dissolution avec liquidation, un ou plusieurs liquidateurs sont nomm\u00E9s le cas \u00E9ch\u00E9ant par",
      "change_kind": "restated",
      "article_title": "DISSOLUTION \u2013 LIQUIDATION - PR\u00C9F\u00C9RENCE DE LIQUIDATION",
      "article_number": "26"
    },
    {
      "summary": "In case of a Liquidation Event, the proceeds will be paid as follows: A. The holder of Preferential Shares has the right to receive, before and in preference to all other shareholders, payment of an amount equal to one (1) times the subscription price paid by this holder for the Preferential Shares ",
      "new_text": "En cas d\u2019un \u00C9v\u00E9nement de Liquidation (tel que d\u00E9fini ci-dessous), tout produit sera pay\u00E9 comme suit :\nA. Le d\u00E9tenteur d\u0027Actions Pr\u00E9f\u00E9rentielles a le droit de recevoir, avant et de pr\u00E9f\u00E9rence par",
      "change_kind": "restated",
      "article_title": "PR\u00C9F\u00C9RENCE DE LIQUIDATION",
      "article_number": "27"
    }
  ],
  "governance_change": {
    "organ_kind_after": "collegial",
    "organ_kind_before": null,
    "admin_delegated_added": [
      {
        "name": "Newton Biocapital I",
        "excluded_powers": []
      },
      {
        "name": "NOSHAQ and Investsud Tech",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": "twee_gezamenlijk",
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Berquin Notarissen BV/SRL",
    "person_name": null,
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "huit procurations",
    "le texte coordonn\u00E9 des statuts",
    "le rapport de l\u0027organe d\u0027administration",
    "le rapport du commissaire \u00E9tabli en application de l\u0027article 7:155 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport de l\u0027organe d\u0027administration et le rapport du commissaire \u00E9tabli en application des articles 7:179, \u00A71, deuxi\u00E8me alin\u00E9a et 7:197, \u00A71, deuxi\u00E8me alin\u00E9a du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": true,
    "liquidation_preference_text": "En cas d\u2019un \u00C9v\u00E9nement de Liquidation (tel que d\u00E9fini ci-dessous), tout produit sera pay\u00E9 comme suit :\nA. Le d\u00E9tenteur d\u0027Actions Pr\u00E9f\u00E9rentielles a le droit de recevoir, avant et de pr\u00E9f\u00E9rence par rapport \u00E0 tous les autres actionnaires, le paiement d\u0027un montant \u00E9gal \u00E0 une (1) fois le prix de souscription pay\u00E9 par ce d\u00E9tenteur pour les Actions Pr\u00E9f\u00E9rentielles qu\u0027il d\u00E9tient au moment de l\u0027\u00C9v\u00E9nement de Liquidation (la Pr\u00E9f\u00E9rence de Liquidation Pr\u00E9f\u00E9rentielle);\nB. Apr\u00E8s distribution de la Pr\u00E9f\u00E9rence de Liquidation Pr\u00E9f\u00E9rentielle, les d\u00E9tenteurs d\u2019Actions Ordinaires auront le droit de recevoir, le paiement d\u2019un montant conform\u00E9ment aux principes pr\u00E9vus dans la Convention d\u2019Actionnaires (la Pr\u00E9f\u00E9rence de Liquidation Ordinaire) ;\nC. Apr\u00E8s la distribution de la Pr\u00E9f\u00E9rence de Liquidation Pr\u00E9f\u00E9rentielle en faveur du d\u00E9tenteur des Actions Pr\u00E9f\u00E9rentielles et de la Pr\u00E9f\u00E9rence de Liquidation Ordinaire en faveur des d\u00E9tenteurs des Actions Ordinaires, et dans la mesure o\u00F9 il reste des produits de cet \u00C9v\u00E9nement de Liquidation apr\u00E8s la distribution de la Pr\u00E9f\u00E9rence de Liquidation Pr\u00E9f\u00E9rentielle et la Pr\u00E9f\u00E9rence de Liquidation Ordinaire, le produit et les actifs restants seront distribu\u00E9s \u00E0 tous les actionnaires au prorata de leur participation sur la base de l\u0027\u00E9tat de conversion.",
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": true
  },
  "voorwerp_change_summary": "The object of the company was comprehensively restated to include a broad range of activities related to pharmaceutical, veterinary, and biological products, as well as medical supplies and personalized medicine. The company is authorized to perform all commercial, industrial, real estate, movable, or financial operations directly or indirectly related to its object.",
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "capital_increase_kind",
      "share_class_creation",
      "share_class_merge",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 2300342,
    "shares_before": null,
    "capital_after_eur": 16683478.0,
    "capital_before_eur": 8598171.15,
    "share_classes_after": [
      {
        "count": 1119227,
        "label": "Actions Ordinaires",
        "rights_summary": "Voting rights: 1 per share",
        "voting_per_share": 1.0
      },
      {
        "count": 1181115,
        "label": "Actions Pr\u00E9f\u00E9rentielles",
        "rights_summary": "Voting rights: 3 per share",
        "voting_per_share": 3.0
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "rep_rotation",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Guillaume Oscar C. (Guy) Heynen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-01",
      "evidence_quote": "Guillaume Oscar C. (Guy) Heynen a \u00E9t\u00E9 d\u00E9sign\u00E9 en tant que nouveau repr\u00E9sentant permanent de l\u0027entreprise Newton Biocapital Partners BV, administrateur-personne morale, rempla\u00E7ant Els Hubloux avec effet au 1 avril 2024, pour une p\u00E9riode de deux mois se terminant le 1 juin 2024.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 2
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": "Els Hubloux",
      "effective_date_qualifier": null
    },
    {
      "kind": "rep_rotation",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Jean Combalbert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-01",
      "evidence_quote": "A partir du 1 juin 2024, Jean Combalbert sera d\u00E9sign\u00E9 en tant que nouveau repr\u00E9sentant permanent de l\u0027entreprise Newton Biocapital Partners BV, administrateur-personne morale, rempla\u00E7ant Guillaume Oscar C. (Guy) Heynen.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": "Guillaume Oscar C. (Guy) Heynen",
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Timothy Perera",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-01",
      "evidence_quote": "La composition du conseil d\u0027administration de la Soci\u00E9t\u00E9 en date du 1 avril 2024 est confirm\u00E9e: \u2022 Timothy Perera, administrateur;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Serge Sagodira",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-01",
      "evidence_quote": "La composition du conseil d\u0027administration de la Soci\u00E9t\u00E9 en date du 1 avril 2024 est confirm\u00E9e: \u2022 Serge Sagodira, administrateur;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Guillaume Oscar C. (Guy) Heynen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-01",
      "evidence_quote": "Newton Biocapital Partners SRL/BV, repr\u00E9sent\u00E9e de mani\u00E8re permanente par Guillaume Oscar C. (Guy) Heynen, administrateur,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Gustaaf Van Reet",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "VIZIPHAR Biosciences SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-01",
      "evidence_quote": "VIZIPHAR Biosciences SRL/BV, repr\u00E9sent\u00E9e de mani\u00E8re permanente par Gustaaf Van Reet, administrateur,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "H\u00E9l\u00E8ne Sabatel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-01",
      "evidence_quote": "NOSHAQ PARTNERS SRL/BV, repr\u00E9sent\u00E9e de mani\u00E8re permanente par H\u00E9l\u00E8ne Sabatel, administrateur,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Timothy Perera",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-01",
      "evidence_quote": "La composition du conseil d\u0027administration de la Soci\u00E9t\u00E9 en date du 1 juin 2024 est confirm\u00E9e: \u2022 Timothy Perera, administrateur;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Serge Sagodira",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-01",
      "evidence_quote": "La composition du conseil d\u0027administration de la Soci\u00E9t\u00E9 en date du 1 juin 2024 est confirm\u00E9e: \u2022 Serge Sagodira, administrateur;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Jean Combalbert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-01",
      "evidence_quote": "Newton Biocapital Partners SRL/BV, repr\u00E9sent\u00E9e de mani\u00E8re permanente par Jean Combalbert, administrateur,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Gustaaf Van Reet",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "VIZIPHAR Biosciences SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-01",
      "evidence_quote": "VIZIPHAR Biosciences SRL/BV, repr\u00E9sent\u00E9e de mani\u00E8re permanente par Gustaaf Van Reet, administrateur,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "H\u00E9l\u00E8ne Sabatel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS SRL/BV",
        "address": null,
        "country": null,
        "legal_form": "SRL/BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-06-01",
      "evidence_quote": "NOSHAQ PARTNERS SRL/BV, repr\u00E9sent\u00E9e de mani\u00E8re permanente par H\u00E9l\u00E8ne Sabatel, administrateur,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-07-22",
    "filing_date": "2025-06-20",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d\u0027administration",
      "date": "2025-04-29",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nicolas Bosschaerts",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean Combalbert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Newton Biocapital Partners BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-06-01",
      "evidence_quote": "A partir du 1 juin 2024, Jean Combalbert sera d\u00E9sign\u00E9 en tant que nouveau repr\u00E9sentant permanent de l\u0027entreprise Newton Biocapital Partners BV, administrateur-personne morale, rempla\u00E7ant Guillaume Oscar C. (Guy) Heynen."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1650020,
      "currency": "EUR",
      "after_eur": 8598171.15,
      "delta_eur": 1650020.0,
      "before_eur": 6948151.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-06-06",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 1.650.020 EUR, pour le porter de 6.948.151,15 EUR \u00E0 8.598.171,15 EUR.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 8598171.15,
      "delta_eur": 1650020.0,
      "before_eur": 6948151.15,
      "share_emission": {
        "agio_eur": 1650020.0,
        "share_form": "no_nominal_value",
        "share_class": "Classe B",
        "n_new_shares": 119558,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.8
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 1650020.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-06-20",
    "filing_date": "2024-06-18",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2024-06-06",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procurations",
    "rapports de l\u2019organe d\u2019administration",
    "commissaire",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 52000,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 339476,
      "class_name": "Pr\u00E9f\u00E9rentielles de Classe A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 431130,
      "class_name": "Pr\u00E9f\u00E9rentielles de Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Veerle Catry",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0431088289",
        "name": "B.D.O. R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e B.D.O. R\u00E9viseurs d\u0027Entreprises (num\u00E9ro d\u0027entreprise 0431.088.289), situ\u00E9 \u00E0 Rue Da Vinci 9, bo\u00EEte E6, 1930 Zaventem, en tant que commissaire de la Soci\u00E9t\u00E9 pour une dur\u00E9e de trois ann\u00E9es comptables, dont la premi\u00E8re est 2023. Ce"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 6948151.15,
      "delta_eur": 150000.0,
      "before_eur": 6798151.15,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "B",
        "n_new_shares": 10869,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.8
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 150000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-28",
    "filing_date": "2023-06-26",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-06-26",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procuration",
    "rapport de l\u0027organe d\u0027administration",
    "rapport du r\u00E9viseur",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 52000,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 339476,
      "class_name": "Pr\u00E9f\u00E9rentielles de Classe A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 311572,
      "class_name": "Pr\u00E9f\u00E9rentielles de Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 150000,
      "currency": "EUR",
      "after_eur": 6948151.15,
      "delta_eur": 150000.0,
      "before_eur": 6798151.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-06-20",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de cent cinquante mille euros (\u20AC 150.000,00), pour le porter de six millions sept cent quatre-vingt-dix-huit mille cent cinquante et un euros et quinze centimes (\u20AC 6.798.151,15) \u00E0 six millions neuf cent quarante-huit mille cent cinquante et un euros et quinze centimes (\u20AC 6.948.151,15).",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 4715000.15,
      "delta_eur": 3650004.0,
      "before_eur": 1064996.15,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Pr\u00E9f\u00E9rentielles de Classe B",
        "n_new_shares": 264474,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.8
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 3650004.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 264474,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 6798151.15,
      "delta_eur": 2083151.0,
      "before_eur": 4715000.15,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "NEWTON BIOCAPITAL I, PRICAF PRIV\u00C9E DE DROIT BELGE",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": "schuldvordering",
          "n_shares_subscribed": 200104,
          "contribution_amount_eur": 2083151.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 200104,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "schuldvordering_inbreng",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "nomination",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "procuration",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-01-02",
    "filing_date": "2022-12-29",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-12-20",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "BDO R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Veerle Catry"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Deloitte Legal Lawyers SRL",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procurations",
    "rapports de l\u2019organe d\u2019administration",
    "rapports du r\u00E9viseurs d\u2019entreprises",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "SAGODIRA Serge Jean Jacques",
      "role": "g\u00E9rant_statutaire",
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "NOSHAQ PARTNERS",
      "role": "g\u00E9rant_statutaire",
      "n_shares": null,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 52000,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 339476,
      "class_name": "Pr\u00E9f\u00E9rentielles de Classe A",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 300703,
      "class_name": "Pr\u00E9f\u00E9rentielles de Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 3650004,
      "currency": "EUR",
      "after_eur": 4715000.15,
      "delta_eur": 3650004.0,
      "before_eur": 1064996.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-12-20",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 3.650.004 EUR, pour le porter de 1.064.996,15 EUR \u00E0 4.715.000,15 EUR. L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 2083151,
      "currency": "EUR",
      "after_eur": 6798151.15,
      "delta_eur": 2083151.0,
      "before_eur": 4715000.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-12-20",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 2.083.151 EUR, pour le porter de 4.715.000,15 EUR \u00E0 6.798.151,15 EUR, par l\u2019\u00E9mission de 163.875 Actions Pr\u00E9f\u00E9rentielles de Classe A et 36.229 Actions Pr\u00E9f\u00E9rentielles de Classe B ... L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation du capital sera r\u00E9alis\u00E9e par l\u2019apport par la soci\u00E9t\u00E9 anonyme \u00AB NEWTON BIOCAPITAL I ... de sa cr\u00E9ance certaine, liquide et exigible",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": true,
    "object_change": false,
    "effective_date": "2022-06-29",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Christoph Michiels, Sander Kevelaerts, Elena Vromans et tout autre avocat de\u0022 Deloitte Legal - Lawyers\u0022... avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Deloitte Legal - Lawyers",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Luik",
        "region": "Waals",
        "street": "Clos Chanmurly",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "13"
      },
      "old_address": {
        "city": "Geel",
        "region": "Vlaams",
        "street": "Oudepostelseweg",
        "country": "BE",
        "postcode": "2440",
        "box_number": null,
        "street_number": "1"
      },
      "effective_date": "2022-06-29",
      "evidence_quote": "De vergadering beslist de zetel te verplaatsen naar het Waalse Gewest, te Centre AFINIS BUSINESS CENTER - Clos Chanmurly 13, 4000 Luik."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Timothy Perera",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-03-01",
      "evidence_quote": "de heer Timothy Perera wonende te Oudepostelseweg 1, 2440 Geel, Belgi\u00EB, te benoemen als dagelijks bestuurder van de Vennootschap en dit met ingang vanaf heden voor een periode van onbepaalde duur."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gustaaf Van Reet",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "VIZIPHAR Biosciences BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-03-01",
      "evidence_quote": "VIZIPHAR Biosciences BV, vertegenwoordigd door haar vaste vertegenwoordiger de heer Gustaaf Van Reet, te benoemen als voorzitter van de raad van bestuur van de Vennootschap en dit met ingang vanaf heden voor een periode van onbepaalde duur."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2021-02-04",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "NV"
  },
  "signature_regime": "joint_two",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 999.996,
      "currency": "EUR",
      "after_eur": 1064996.15,
      "delta_eur": 999996.15,
      "before_eur": 65000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-02-04",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 999.996,15 EUR, om het van 65.000,00 EUR te brengen op 1.064.996,15 EUR door inbreng in geld",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DEUTERONCOLOGY",
    "legal_form": "NV"
  }
}

{
  "kind": "oprichting",
  "seat": "Oudepostelseweg 1, 2440 Geel",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "PERERA Timothy Pietro Suren",
        "niss": null,
        "address": "Oudepostelseweg 1, 2440 Geel"
      },
      "share_class": "naamloze aandelen",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 65000,
      "holder_person_name": "PERERA Timothy Pietro Suren",
      "is_subscriber_only": true,
      "n_shares_subscribed": 65000,
      "amount_subscribed_eur": 65000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 65000,
  "subject_company": {
    "kbo": "0754.971.388",
    "name_full": "DeuterOncology",
    "legal_form": "NV"
  },
  "initial_directors": [],
  "incorporation_date": "2020-09-23",
  "post_incorporation_mandates": []
}